KACIE STOLL: Open Payments
NPI 1770099079 · CLINTON TOWNSHIP, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$784 in 25 payments from 12 companies in 2025. Trend: 2023 $199 · 2024 $415 · 2025 $784
Food & beverage: $599Education: $184
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 6 | $261 |
| GENZYME CORPORATION | 5 | $120 |
| Regeneron Healthcare Solutions, Inc. | 2 | $110 |
| Novartis Pharmaceuticals Corporation | 4 | $66 |
| E.R. Squibb & Sons, L.L.C. | 1 | $55 |
| UCB, Inc. | 1 | $39 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $26 |
| Amgen Inc. | 1 | $26 |
| Incyte Corporation | 1 | $23 |
| Botanix SB Inc | 1 | $22 |
Products named: TREMFYA, DUPIXENT, COSENTYX, Sotyktu, Bimzelx, SPEVIGO, OTEZLA, OPZELURA.
Industry payments across MI — which companies pay providers there.
